Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, post-series A-funded, therapeutic Biotech companies.
Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants.
There’s nothing that comes close to hearing the honest advice and experience of peers treading the same path as you. LSX’s CEO Forums offer executives the chance to exchange ideas with and seek advice from peers in a private group setting. They are an opportunity to share learnings, best practice and some great thinking, as well as meeting other influential people to support your business journey. Capped at 20 participants, the forums operate under strict Chatham House Rule.
11:15am Welcome and Introductions
11:20am Future of building biotech .. evolution or revolution
In an ever changing commercial and regulatory landscape do biotech need to adapt their approach to building their business
John Westwood, Partner & Global Life Sciences Business Leader, Oliver Wyman
11:45am Trends in Licensing and Collaborations
This session will cover:
Alan Tamarelli, Partner, Cooley LLP
12:10pm The thrills and challenges of building successful growing biotech companies
Robert Barrow, CEO, MindMed
12:25pm General Discussion (suggested topics to include but not limited to)